Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Receivables - Net (2016 - 2025)

Abeona Therapeutics has reported Receivables - Net over the past 14 years, most recently at $3.0 for Q4 2025.

  • Quarterly results put Receivables - Net at $3.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $3.0 (changed N/A YoY), and the annual figure for FY2025 was $3.0, changed.
  • Receivables - Net for Q4 2025 was $3.0 at Abeona Therapeutics, down from $3.5 million in the prior quarter.
  • Over the last five years, Receivables - Net for ABEO hit a ceiling of $3.5 million in Q2 2023 and a floor of $3.0 in Q4 2025.
  • Median Receivables - Net over the past 4 years was $1.0 million (2022), compared with a mean of $1.7 million.
  • Peak annual rise in Receivables - Net hit 250.0% in 2023, while the deepest fall reached 250.0% in 2023.
  • Abeona Therapeutics' Receivables - Net stood at $3.0 million in 2021, then crashed by 65.1% to $1.0 million in 2022, then skyrocketed by 234.29% to $3.5 million in 2023, then plummeted by 100.0% to $3.0 in 2025.
  • The last three reported values for Receivables - Net were $3.0 (Q4 2025), $3.5 million (Q2 2023), and $1.0 million (Q3 2022) per Business Quant data.